The Impact of Intelligent Nursing Based on Health Cloud Platform on Active Health Management of Urostomy Patients

Brief summary (registry, in English)

Research data show that the incidence of bladder tumors in China ranks first among malignant tumors of the urinary system and is on the rise . Muscle - invasive bladder tumor is a fatal malignant tumor, and radical cystectomy with urinary diversion is the main treatment method . After urinary diversion, patients rely on urostomy for urination for life, unable to control urine at will, and need to wear ostomy bags for life, resulting in self - image disorder. Urostomy brings a lot of troubles to patients and their families, increases the economic burden, especially makes young patients feel anxious about life, lose confidence in the future, and causes great psychological pressure . Due to the strong professionalism of stoma care, with the improvement of medical technology, the average hospital stay of patients after surgery is shortened, resulting in patients not fully mastering the knowledge and skills of urostomy care at the time of discharge, and their self - care ability is at a low level. They are prone to various health problems, which directly affects the quality of life of patients and their families . Health is an inevitable requirement for the all - around development of people. The "Healthy China 2030" Plan Outline emphasizes the concept of proactive health. Proactive health refers to long - term, continuous and dynamic tracking of an individual's behavior system, identification and assessment of one's own state, evolution direction and degree, selection of various elements of lifestyle as the main means, giving full play to one's subjective initiative, and conducting controllable interventions on human behavior to improve health behaviors. In 2017, the Ministry of Science and Technology issued a notice officially including proactive health in the special plan. The concept of proactive health management has become an important part of realizing the Healthy China strategy.

What you commit to

• Study type: Interventional
• Participants enrolled: 42
• From 31 Jan 2023 to the primary completion date, 12 May 2025
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.